Center for Drug Evaluation and Research


Also found in: Acronyms, Wikipedia.

Center for Drug Evaluation and Research

,

CDER

A division of the U.S. Food and Drug Administration that reviews and oversees the manufacture of pharmaceuticals distributed to U.S. citizens and provides clinical information about the uses and hazards of drugs. Website: www.fda.gov/cder/
References in periodicals archive ?
Centex Construction Company's Mid Atlantic Division has received a $21 million contract to perform the tenant buildout for the Food and Drug Administration (FDA) within the Center for Drug Evaluation and Research (CDER) office building in White Oak, Md.
a)The eight FDA Centers and Offices that FDA IT serves are: Center for Biologics Evaluation and Research (CBER), Center for Devices and Radiological Health (CDRH), Center for Drug Evaluation and Research (CDER), Center for Food Safety and Applied Nutrition (CFSAN), Center for Veterinary Medicine (CVM), National Center for Toxicological Research (NCTR), Office of the Commissioner (OC), and the Office of Regulatory Affairs (ORA).
Convera (NASDAQ:CNVR), a leading provider of search and categorization software for enterprises and government agencies, today announced expanded use of the company's RetrievalWare search technology by approximately 2,500 scientific review staff within the Center for Drug Evaluation and Research (CDER) at the FDA.
Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) a gene expression data set derived from vehicle-treated rat liver samples.
Food and Drug Administration, Center for Drug Evaluation and Research (CDER) under a collaborative agreement to develop metrics for quality evaluation and normalization of microarray data and to develop standards for submission of microarray data as part of CDER's study of the application of genomic technologies in the regulatory approval process.
Food and Drug Administration, Center for Drug Evaluation and Research (CDER) under a collaborative agreement to develop metrics for quality evaluation and normalization of microarray data, as well as efforts to develop standards for submission of microarray data as part of CDER's study of the application of genomic technologies in the regulatory approval process.
Food and Drug Administration, Center for Drug Evaluation and Research (CDER) under an agreement to advance CDER's study of the application of genomic technologies in the regulatory approval process.
Full browser ?